Alterations of left ventricular hypertrophy in and survival of patients receiving hemodialysis: follow-up of an interventional study
GM London, B Pannier, AP Guerin… - Journal of the …, 2001 - journals.lww.com
Left ventricular (LV) hypertrophy (LVH) is a risk factor for mortality in patients with end-stage
renal disease (ESRD). Whether the attenuation of LVH has a positive effect on survival of
patients with ESRD has not been documented. The aim of this study was to determine the
effect of parallel treatment of hypertension and anemia on LV mass (LVM) and to determine
the effect of LVM changes on survival. A cohort of 153 patients receiving hemodialysis was
studied. The duration of follow-up was 54±37 mo. All patients had echocardiographic …
renal disease (ESRD). Whether the attenuation of LVH has a positive effect on survival of
patients with ESRD has not been documented. The aim of this study was to determine the
effect of parallel treatment of hypertension and anemia on LV mass (LVM) and to determine
the effect of LVM changes on survival. A cohort of 153 patients receiving hemodialysis was
studied. The duration of follow-up was 54±37 mo. All patients had echocardiographic …